1.
|
Phase: Phase IV
Type: Diagnostic, Supportive care, Treatment
Status: Active
Age: 40 to 65
Sponsor: Other
Protocol IDs: 2004/949, NCT00111241
|
|
2.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: STARS-Pilot (05/55 Graham), NCT00126360
|
|
3.
|
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 40 to 70
Sponsor: NIGMS
Protocol IDs: 0412-14, UO1-GM61373-06, NCT00228956
|
|
4.
|
Phase: Phase IV
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 100943, NCT00195533
|
|
5.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CFEM345C2403, NCT00171847
|
|
6.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: Postmenopausal to 65
Sponsor: Pharmaceutical / Industry
Protocol IDs: 1033MX/001, NCT00262535
|
|
7.
|
Phase: Phase IV
Type: Diagnostic
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: UMC Utrecht, NCT00302120
|
|
8.
|
Phase: Phase IV
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: seromprotocol, NCT00307606
|
|
9.
|
Phase: Phase IV
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CZOL446EDE28, NCT00334139
|
|
10.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: EGF103659, NCT00338247
|
|
11.
|
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 45
Sponsor: Other
Protocol IDs: 0501-37, NCT00352872
|
|
12.
|
Phase: Phase IV
Type: Supportive care, Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: MAR-YC-2003-0111, NCT00356148
|
|
13.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: Over 18
Sponsor: Pharmaceutical / Industry
Protocol IDs: CZOL446EIT14, NCT00375427
|
|
14.
|
Phase: Phase IV
Type: Supportive care
Status: Active
Age: 2 and over
Sponsor: Other
Protocol IDs: 2005-004973-55, ANTIVORIFUNGOL, NCT00386802
|
|
15.
|
Phase: Phase IV
Type: Screening
Status: Active
Age: 25 to 70
Sponsor: Other
Protocol IDs: DBCG07MRBRCA, DBCG07MRBRCA, NCT00413491
|
|
16.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: SPRI-P04445, EU-20654, NCT00266799, SPRI-PELICAN
|
|
17.
|
Phase: Phase IV
Type: Supportive care
Status: Active
Age: 20 to 75
Sponsor: Other
Protocol IDs: UCSD 060340, ESRC 054, NCT00365261
|
|
18.
|
Phase: Phase IV
Type: Natural history/Epidemiology, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CZOL446EAU22, NCT00434447
|
|
19.
|
Phase: Phase IV
Type: Natural history/Epidemiology
Status: Active
Age: Under 50
Sponsor: Other
Protocol IDs: ZEG2006_02, NCT00461253
|
|
20.
|
Phase: Phase IV
Type: Supportive care
Status: Active
Age: 65 and over
Sponsor: Other
Protocol IDs: PRO06080002 (REBBeCA II), NCT00485953
|
|
21.
|
Phase: Phase IV
Type: Educational/Counseling/Training, Health services research
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RO1U01CA116924, NCT00496678
|
|
22.
|
Phase: Phase IV
Type: Diagnostic, Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: LITE Randomized Pilot Study, NCT00531973
|
|
23.
|
Phase: Phase IV
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: GeneSearch BLN Timing Study, BLN-TIMING-2007.00, NCT00595023
|
|
24.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 65 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: P05059, NCT00604968
|
|
25.
|
Phase: Phase IV
Type: Health services research
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: U01-CA-116892-03, U01-CA-116892-03, NCT00613275
|
